LLY - Eli Lilly purchase of Point Bio to close Wednesday after tender offer completed
2023-12-26 07:43:47 ET
More on POINT Biopharma Global
- Why POINT Biopharma Global Is At Least A Hold On Disappointing Readout
- POINT Biopharma Global: Why The Market Believes That A Second Bidder May Emerge
- Eli Lilly POINTs Toward Radiopharmaceutical Ambitions
- Lilly extends tender offer for POINT Biopharma to Dec. 22
- Lantheus, Point BioPharma drop amid results of SPLASH study on prostate cancer
For further details see:
Eli Lilly purchase of Point Bio to close Wednesday after tender offer completed